A2 Bio Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
124
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$80M
- Investors
-
15
A2 Bio General Information
Description
Developer of a cell therapy designed to cure cancer via tumor-specific targeting. The company engineers tumor cells that target the loss of genetic material in tumors through the selective killing of tumor cells while leaving normal cells unharmed, enabling physicians to revolutionize the treatment of solid tumors.
Contact Information
Website
www.a2bio.comCorporate Office
- 30301 Agoura Road
- Suite 210
- Agoura Hills, CA 91301
- United States
Corporate Office
- 30301 Agoura Road
- Suite 210
- Agoura Hills, CA 91301
- United States
A2 Bio Timeline
A2 Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series C) | 09-Jan-2025 | $80M | Completed | Clinical Trials - Phase 1 | ||
| 5. Later Stage VC (Series B) | 16-Dec-2022 | Completed | Pre-Clinical Trials | |||
| 4. Early Stage VC (Series B) | 05-Feb-2021 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series B) | 30-Sep-2020 | Completed | Pre-Clinical Trials | |||
| 2. Early Stage VC (Series A) | 05-Nov-2019 | $57M | $64.5M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC (Series A1) | 01-Apr-2018 | $7.5M | $7.5M | Completed | Startup |
A2 Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B | ||||||||
| Series A-1 | 6,000,000 | $0.000010 | 6% | $1.25 | $1.25 | 1x | $1.25 | 1.59% |
| Series A | 57,000,000 | $0.000010 | 6% | $1 | $1 | 1x | $1 | 15.06% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
A2 Bio Comparisons
Industry
Financing
Details
A2 Bio Competitors (42)
One of A2 Bio’s 42 competitors is Kite Pharma, a Formerly VC-backed company based in Santa Monica, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kite Pharma | Formerly VC-backed | Santa Monica, CA | ||||
| Adicet Bio | Formerly VC-backed | Boston, MA | ||||
| Genocea Biosciences | Formerly VC-backed | Cambridge, MA | ||||
| RAPT Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA |
A2 Bio Patents
A2 Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026226857-A1 | Compositions and methods for treating blood cancers | Pending | 23-Apr-2025 | ||
| WO-2026198474-A1 | Universal allogenic transplant for treatment for cancer associated with loss of heterozygosity | Pending | 17-Mar-2025 | ||
| WO-2026147809-A1 | Compositions and methods for treating blood cancers | Pending | 31-Dec-2024 | ||
| WO-2026060446-A1 | Engineered interleukins and uses thereof | Pending | 16-Sep-2024 | ||
| WO-2026030629-A1 | Compositions and methods for treating cancers | Pending | 31-Jul-2024 | C07K16/3007 |
A2 Bio Signals
A2 Bio Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BCM Ventures | Venture Capital | Minority | ||
| Mana Ventures | Venture Capital | Minority | ||
| Merck & Co. | Corporation | Minority | ||
| S32 | Venture Capital | Minority | ||
| Schroders | Asset Manager | Minority |
A2 Bio FAQs
-
When was A2 Bio founded?
A2 Bio was founded in 2017.
-
Where is A2 Bio headquartered?
A2 Bio is headquartered in Agoura Hills, CA.
-
What is the size of A2 Bio?
A2 Bio has 124 total employees.
-
What industry is A2 Bio in?
A2 Bio’s primary industry is Drug Discovery.
-
Is A2 Bio a private or public company?
A2 Bio is a Private company.
-
What is the current valuation of A2 Bio?
The current valuation of A2 Bio is .
-
What is A2 Bio’s current revenue?
The current revenue for A2 Bio is .
-
How much funding has A2 Bio raised over time?
A2 Bio has raised $353M.
-
Who are A2 Bio’s investors?
BCM Ventures, Mana Ventures, Merck & Co., S32, and Schroders are 5 of 15 investors who have invested in A2 Bio.
-
Who are A2 Bio’s competitors?
Kite Pharma, Adicet Bio, Genocea Biosciences, RAPT Therapeutics, and Inovio Pharmaceuticals are some of the 42 competitors of A2 Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process